Coral Laboratories share news, announcements and annual reports
BSE: 524506Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹484.35.
2 Nov: open ₹498.00, high ₹500.00, low ₹480.15
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹179 Cr2,551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.29
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.40%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 875
Coral Laboratories share news and announcements
720 announcements, routine notices left out, newest first. Page 7 of 15.
Oct 2020
13 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....13 Oct · Compliance Certificate From PCS As Per Regulation 40(9) And 40(10) Under Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
7 Oct · Compliance Certificate From RTA And Compliance Officer As Per Regulation 7(3) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
7 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
18 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....18 Sep · VOTING RESULT UNDER REGULATION 44 UNDER SEBI(LISTING OBLIGATION AND DISCLOSURE REQUIREMENT,REGULATION 2015
4 Sep · Board meeting
Aug 2020
31 Aug · Board meeting
Meeting on 4 Sep 2020: quarterly results20 Aug · Reg. 34 (1) Annual Report
10 Aug · Legal
Exchange has sought clarification from Coral Laboratories Ltd on August 10, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jul 2020
23 Jul · Intimation Of Contact Details Of KMP For Reporting Of Material Events Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements} Regulations. 2015.
23 Jul · Board meeting
20 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....17 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 017 Jul · Board meeting
Meeting on 23 Jul 2020
Jun 2020
19 Jun · Management
18 Jun · Disclosure Of Related Party Transactions For The Half Year Ended 31St March,2020
15 Jun · Board meeting
Meeting on 19 Jun 2020
May 2020
20 May · Results
15 May · Board meeting
Meeting on 20 May 2020: audited results11 May · Compliance Certificate From PCS As Per Regulation 40(9)And 40(10) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015.
6 May · Compliance Certificate From RTA As Per Regulation 7(3) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
4 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Apr 2020
15 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 015 Apr · Legal
Exchange has sought clarification from Coral Laboratories Ltd on April 15th , 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Feb 2020
3 Feb · Board meeting
Meeting on 12 Feb 2020: quarterly results
Jan 2020
8 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....4 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2019
18 Nov · Disclosure Under Reg. 23(9) Of SEBI (LODR) Regulations, 2015